Willow Biosciences reports significant loss and imminent closure
Biotechnology firm Willow Biosciences (TSX:WLLW) reported a net loss of C$6.1 million in 2024, despite achieving a roughly ...
Green Market Report13d
Willow Biosciences to cease operations following sale of subsidiary
Willow said in a press release that CEO Dr. Chris Savile and Senior Vice President of Research and Development Dr. Trish ...
Breast pump startup Willow acquires assets of Elvie as UK women’s health pioneer moves into administration
Women's health and its startups building connected breast pumps, period trackers, and other apps and hardware designed for ...